Editing Oxycodone (section)

=====Lawsuits=====
In October 2017, ''[[The New Yorker]]'' published a story on [[Mortimer Sackler]] and [[Purdue Pharma]] regarding their ties to the production and manipulation of the oxycodone markets.<ref name="eop" /> The article links Raymond and Arthur Sackler's business practices with the rise of direct pharmaceutical marketing and eventually to the rise of addiction to oxycodone in the United States. The article implies that the [[Sackler family]] bears some responsibility for the [[opioid epidemic in the United States]].<ref name="NewYorker_Keefe_20171023">{{Cite magazine|vauthors=Keefe PR|date=23 October 2017|title=The Family That Built an Empire of Pain|magazine=[[The New Yorker]]|url=https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain|access-date=18 November 2017|issn=0028-792X|archive-date=22 January 2018|archive-url=https://web.archive.org/web/20180122073308/https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain|url-status=live}}</ref> In 2019, ''[[The New York Times]]'' ran a piece confirming that [[Richard Sackler]], the son of Raymond Sackler, told company officials in 2008 to "measure our performance by Rx's by strength, giving higher measures to higher strengths".<ref>{{Cite news|vauthors=Meier B|date=31 January 2019|title=Sackler Scion's Email Reveals Push for High-Dose OxyContin, New Lawsuit Disclosures Claim|work=The New York Times|url=https://www.nytimes.com/2019/01/31/health/opioids-purdue-pharma-sackler.html|access-date=3 February 2019|issn=0362-4331|archive-date=2 February 2019|archive-url=https://web.archive.org/web/20190202180610/https://www.nytimes.com/2019/01/31/health/opioids-purdue-pharma-sackler.html|url-status=live}}</ref> This was verified with documents tied to a lawsuit – which was filed by the Massachusetts attorney general, [[Maura Healey]] – claiming that Purdue Pharma and members of the Sackler family knew that high doses of OxyContin over long periods would increase the risk of serious side effects, including addiction.<ref>{{cite news|vauthors=Bebinger M, Willmsen C|date=15 January 2019|title=Mass. AG Implicates Family Behind Purdue Pharma In Opioid Deaths|work=WBUR Boston|url=https://www.wbur.org/commonhealth/2019/01/15/healey-purdue-oxycontin-sacklers-unredacted-complaint|access-date=19 September 2019|archive-date=16 October 2019|archive-url=https://web.archive.org/web/20191016135025/https://www.wbur.org/commonhealth/2019/01/15/healey-purdue-oxycontin-sacklers-unredacted-complaint|url-status=live}}</ref> Despite Purdue Pharma's proposal for a US$12 billion settlement of the lawsuit, the attorneys general of 23 states, including Massachusetts, rejected the settlement offer in September 2019.<ref>{{cite news|vauthors=DeCosta-Klipa N|date=17 September 2019|title=Maura Healey explains why she refused to join the Purdue Pharma settlement|work=Boston.com|publisher=Boston Globe Media Partners, LLC|url=https://www.boston.com/news/politics/2019/09/17/maura-healey-purdue-settlement|access-date=19 September 2019|archive-date=17 October 2019|archive-url=https://web.archive.org/web/20191017195611/https://www.boston.com/news/politics/2019/09/17/maura-healey-purdue-settlement|url-status=live}}</ref>